Jin Medical International (ZJYL) 6-K Report of Foreign Private Issuer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2023

Commission File Number: 001-41661

JIN MEDICAL INTERNATIONAL LTD.

(Exact name of registrant as specified in its charter)

No. 33 Lingxiang Road, Wujin District

Changzhou City, Jiangsu Province

People’s Republic of China

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒      Form 40-F  ☐

Resignation of Jing Chen as Chairman of Audit Committee and Board Member

On December 21, 2023, Jing Chen, the chairperson of the audit committee and an independent director of Jin Medical International Ltd. (the “Company”), resigned from her positions with the Company, effective as of such date. The resignation of Jing Chen was not related to any disagreement with the Company’s accounting policies.

1

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	JIN MEDICAL INTERNATIONAL LTD.
Date: December 26, 2023	By:	/s/ Erqi Wang
		Erqi Wang
		Chief Executive Officer

2